<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02662881</url>
  </required_header>
  <id_info>
    <org_study_id>BBIO.CR.BIOAVN.002.15</org_study_id>
    <nct_id>NCT02662881</nct_id>
  </id_info>
  <brief_title>Biologically Assisted Core Decompression of the Femoral Head Using the PerFuse Instrument and BioCUE</brief_title>
  <acronym>REGP-44-00</acronym>
  <official_title>Post-Market Data Collection for Biologically Assisted Core Decompression of the Femoral Head Using the PerFuse Instrument and BioCUE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the performance of biologically assisted core decompression with the&#xD;
      PerFuse instrument and BioCUE in patients with bone lesions in the femoral head. The study&#xD;
      will explore the potential impact of patient demographics and baseline characteristics on&#xD;
      post-operative outcomes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will evaluate the performance of biologically assisted core decompression with the&#xD;
      PerFuse instrument and BioCUE in patients with bone lesions in the femoral head. The study&#xD;
      will explore the potential impact of patient demographics and baseline characteristics on&#xD;
      post-operative outcomes. The study will evaluate change in Harris Hip Score (HHS) at 12&#xD;
      months after treatment. The change in AVN lesion size will also be measured at 12 months&#xD;
      after index treatment via MRI. Change in quality of life and pain measures will be measured&#xD;
      at each follow-up. Adverse events will also be recorded throughout the study.&#xD;
&#xD;
      This study will follow patients for 5 years after initial treatment.&#xD;
&#xD;
      Data will be recorded in a online database that will be entered by the site or patient,&#xD;
      depending on the report form. This database includes data checks to compare entered data&#xD;
      against predefined rules for range.&#xD;
&#xD;
      A risk-based monitoring plan will be put in place for source data verification.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 2016</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Actual">December 8, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Harris Hip Score</measure>
    <time_frame>12 month</time_frame>
    <description>Percentage of patients achieving clinical success at 12 month follow up, being defined as a 20 point increase in the Harris Hip Score from baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of invasive non-study procedures in the hip</measure>
    <time_frame>5 years (all time points)</time_frame>
    <description>Number of hip requiring an non-study invasive procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Second procedure</measure>
    <time_frame>5 years (all time points)</time_frame>
    <description>Number of patients receiving a second study procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hips with no lesion size change</measure>
    <time_frame>12 months</time_frame>
    <description>Number of hips with no change or reduction in lesion size</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>5 years (all time points)</time_frame>
    <description>Number of adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score</measure>
    <time_frame>5 years (all time points)</time_frame>
    <description>number of patients with &quot;Good&quot; or &quot;Excellent&quot; scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D-3L</measure>
    <time_frame>5 years (all time points)</time_frame>
    <description>Change in European Quality of Life 5 Dimensions 3 Levels score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NRS Pain</measure>
    <time_frame>5 years (all time points)</time_frame>
    <description>Change in Numeric Rating Scale for Pain score</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Avascular Necrosis of the Femoral Head</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PerFuse Percutaneous Decompression System</intervention_name>
    <description>Core decompression with PerFuse</description>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BioCUE Platelet Concentration System</intervention_name>
    <description>PRP injection through the PerFuse cannula into core decompression site</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with untreated unilateral or bilateral bone lesion(s) of the femoral head&#xD;
        associated with AVN in need of biologically assisted core decompression.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Willing and able to comply with the study procedures&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
          -  Untreated unilateral or bilateral bone lesion(s) of the femoral head associated with&#xD;
             AVN in need of biologically assisted core decompression. Note:If bilateral untreated&#xD;
             bone lesions of the femoral head associated with AVN,both hips eligible and willing to&#xD;
             undergo study treatment and follow-up&#xD;
&#xD;
          -  ≥ 3 months after arthroplasty (e.g., total, hemi) in the contralateral hip&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or lactating&#xD;
&#xD;
          -  Participating in another device or drug study&#xD;
&#xD;
          -  ARCO stage ≥ III&#xD;
&#xD;
          -  Unable to undergo MRI of the study hip(s)&#xD;
&#xD;
          -  Active, local or systemic infection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher Travers, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Trustees of the University of Pennsylvania</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cecilia Pasucal-Garrido, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joseph Schwab, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical College of Wisconsin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nicolas Piuzzi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Washington University in St. Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation - Orthopaedic and Rheumatologic Institute</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania/ Pennsylvania Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical College Of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>January 18, 2016</study_first_submitted>
  <study_first_submitted_qc>January 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2016</study_first_posted>
  <last_update_submitted>October 19, 2021</last_update_submitted>
  <last_update_submitted_qc>October 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Necrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

